Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
CEOs Plan Widespread AIDriven Layoffs EntryLevel Roles Most at Risk Micron Technologys Surge to 1 Trillion Market Cap Lifts US Stocks to Record Highs Dell Technologies Executive Suggests Quantum Computing Could Reach Scale by 20282029 Potentially Surpassing ChatGPTs Disruption AIs Growing Influence on Quarterly Earnings A Broad Overview EID Parry Posts Q4 Net Loss on Exceptional Charge FY26 Net Profit at 1380 Crore Masco Corporation MAS Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Kestrel Group Ltd Q3 2024 Earnings Net Loss Reported Amid Broader Market Headwinds SSC Technologies Q1 2026 Earnings EPS Slightly Beats Estimates Amid Operational Resilience OLOX Q3 2023 Earnings NarrowerthanExpected Loss Drives 3736 EPS Surprise INMD Q1 2026 Earnings EPS Misses Estimates by 1744 Amid Challenging Quarter AGNC Investment Corp AGNC Edges Higher Amid Mortgage REIT Sector Movements Fermi Inc FRMI Surges 443 Breaking Above Support Testing Key Resistance Levels NovaBay Pharmaceuticals NBY Surges Over 22 as Bullish Momentum Builds PureCycle Technologies PCT Trades Near Support as Slight Decline Signals Consolidation Vancouver Creative Tech Sector Gains Momentum Amid Los Angeles Industry Struggles First Trust SP REIT Index Fund FRI Dividend Drops 10 in 2025 Why Income Investors May Stay Calm Alibaba Unveils Enhanced Zhenwu AI Chip and NextGeneration Large Language Model Ferrari Faces Market Headwinds as Luce EV Design Draws Online Criticism AFYA Q1 2026 Earnings EPS Miss Weighs on Shares Despite Solid Operational Progress STRR Q1 2026 Earnings Significant EPS Miss But Stock Gains 342 NTNX Q1 2026 Earnings EPS Surges Past Estimates Driving Shares Higher Castle Biosciences Inc CSTL Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Optimism Janus Living Q1 2026 Earnings EPS Falls Short of Analyst Expectations Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones